MedPath

Clinical study protocol for the effect of NMES and BCAA on skeletal muscles in patients after LDLT

Phase 2
Conditions
decompensated cirrhosis
Registration Number
JPRN-jRCTs071190051
Lead Sponsor
Miyaaki Hisamitsu
Brief Summary

o analysis will be performed because of serious non-compliance with the study and the study was terminated.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
13
Inclusion Criteria

(1) an individual age; more than 20 years
(2) diagnosed with decompensated liver cirrhosis
(3) Performance Status (PS); 0 to 2
(4) providing written informed consent

Exclusion Criteria

(1) complicated with a bone or a joint disorder that might affect the affect the effectiveness of EMS
(2) complicated with fragile skin disease that might cause skin damage due to EMS
(3) complicated with cerebrovascular disorder
(4) patients undergoing hemodialysis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath